PRESS RELEASE published on 09/06/2024 at 08:00, 2 months 17 days ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc announces repurchase of 150,000 ordinary shares on Euronext Dublin and London Stock Exchange through Goodbody Stockbrokers UC, as part of share buyback program London Stock Exchange Ordinary Shares Cairn Homes Plc Euronext Dublin Repurchase
PRESS RELEASE published on 09/06/2024 at 08:00, 2 months 17 days ago Cairn Homes Plc: Result of Secondary Placing Cairn Homes Plc announces the result of Secondary Placing by Michael Stanley, selling 8.0 million shares at €1.84 per share. Placing settled on T+2 basis Shares Cairn Homes Plc Michael Stanley Goodbody Stockbrokers Secondary Placing
BRIEF published on 09/05/2024 at 17:51, 2 months 18 days ago Cairn Homes Announces Proposed Secondary Placing Accelerated Bookbuild Cairn Homes Michael Stanley Goodbody Stockbrokers Secondary Placing
PRESS RELEASE published on 09/05/2024 at 17:46, 2 months 18 days ago Cairn Homes Plc: Proposed Secondary Placing Cairn Homes Plc announces proposed secondary placing of 8.0 million shares by CEO Michael Stanley through Goodbody Stockbrokers UC Cairn Homes Plc Accelerated Bookbuild Michael Stanley Goodbody Stockbrokers Secondary Placing
BRIEF published on 09/05/2024 at 08:05, 2 months 18 days ago Cairn Homes Plc: Transaction in Own Shares London Stock Exchange Share Buyback Euronext Dublin Repurchase Goodbody Stockbrokers
PRESS RELEASE published on 09/05/2024 at 08:00, 2 months 18 days ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc repurchased 144,119 ordinary shares, part of their buyback program. Highest price paid: €1.9580, Lowest: €1.9300, VWAP: €1.9457 Cairn Homes Plc Repurchase Buyback Program Share Prices VWAP
BRIEF published on 09/04/2024 at 08:05, 2 months 19 days ago Cairn Homes Plc: Transaction in Own Shares London Stock Exchange Ordinary Shares Share Buyback Cairn Homes Plc Euronext Dublin
BRIEF published on 09/04/2024 at 08:05, 2 months 19 days ago Cairn Homes Reports Record Performance for H1 2024 Financial Results Revenue Growth Sustainability Operating Profit Future Outlook
PRESS RELEASE published on 09/04/2024 at 08:00, 2 months 19 days ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc purchased 147,976 of its ordinary shares on Euronext Dublin and London Stock Exchange through Goodbody Stockbrokers UC. Shares will be cancelled as part of buyback program London Stock Exchange Ordinary Shares Share Buyback Cairn Homes Plc Euronext Dublin
PRESS RELEASE published on 09/04/2024 at 08:00, 2 months 19 days ago Cairn Homes Plc: Results for the Six Months Ended 30 June 2024 Cairn Homes plc announces record H1 performance with 67% revenue increase and strategic growth plans. Financial and operational highlights shared Revenue Increase Cairn Homes Plc Growth Plans Financial Highlights Record Performance
Published on 11/22/2024 at 23:55, 1 day ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 1 hour ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 1 hour ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 2 hours ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 1 day 6 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 1 day 6 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 7 hours ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/21/2024 at 06:58, 2 days 17 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 5 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 7 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 7 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
